Malaria vaccines: If at first you don't succeed...

Trends in Parasitology

Volumn 20, Issue 12, 2004, Pages 604-610

  Tongren, Jon Eric ^a   Zavala, Fidel ^b   Roos, David S ^c   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

AUSTRALIA; CHEMOTHERAPY; DATA BASE; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOME; GENOME ANALYSIS; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; LIFE CYCLE; LYMPHOCYTE PROLIFERATION; MALARIA; MALARIA CONTROL; MEDICAL EXPERT; MOLECULAR BIOLOGY; MOSQUITO; PLASMODIUM; PROTECTION; PROTEOMICS; REVIEW; SEQUENCE ANALYSIS; TREATMENT FAILURE;

ANIMALS; ANTIGENS, PROTOZOAN; HUMANS; IMMUNOLOGIC MEMORY; MALARIA; MALARIA VACCINES; PLASMODIUM;

PROTOZOA;

EID: 7444221075     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2004.09.005     Document Type: Review

References (46)

1. S.W. Lindsay, and W.J. Martens Malaria in the African highlands: past, present and future Bull. World Health Organ. 76 1998 33 45
2. D. Schellenberg The changing epidemiology of malaria in Ifakara Town, southern Tanzania Trop. Med. Int. Health 9 2004 68 76
3. T.C. Luke, and S.L. Hoffman Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine J. Exp. Biol. 206 2003 3803 3808
4. D.J. Pombo Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum Lancet 360 2002 610 617
5. S. Struik, and E.M. Riley Does malaria suffer from lack of memory? Immunol. Rev. 201 2004 268 290
6. K. Artavanis-Tsakonas The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology Clin. Exp. Immunol. 133 2003 145 152
7. M.O. Makobongo The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria Proc. Natl. Acad. Sci. U. S. A. 100 2003 2628 2633
8. S.J. McConkey Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat. Med. 9 2003 729 735
9. M.F. Good Towards the development of the ideal malaria vaccine. A decade of progress in a difficult field Med. J. Aust. 154 1991 284 289
10. S. Hoffman Malaria vaccine development 1996 Blackwell Publishing
11. M. Tsuji, and F. Zavala T cells as mediators of protective immunity against liver stages of Plasmodium Trends Parasitol. 19 2003 88 93
12. F.E. Andre Vaccinology: past achievements, present roadblocks and future promises Vaccine 21 2003 593 595
13. V.S. Moorthy Malaria vaccine developments Lancet 363 2004 150 156
14. M.J. Gardner Genome sequence of the human malaria parasite Plasmodium falciparum Nature 419 2002 498 511
15. J.M. Carlton Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii Nature 419 2002 512 519
16. J.C. Kissinger The Plasmodium genome database Nature 419 2002 490 492
17. C. Ben Mamoun Co-ordinated programme of gene expression during asexual intraerythrocytic development of the human malaria parasite Plasmodium falciparum revealed by microarray analysis Mol. Microbiol. 39 2001 26 36
18. Z. Bozdech Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray Genome Biol. 4 2003 R9
19. K.G. Le Roch Discovery of gene function by expression profiling of the malaria parasite life cycle Science 301 2003 1503 1508
20. L. Florens A proteomic view of the Plasmodium falciparum life cycle Nature 419 2002 520 526
21. E. Lasonder Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry Nature 419 2002 537 542
22. D.L. Doolan Utilization of genomic sequence information to develop malaria vaccines J. Exp. Biol. 206 2003 3789 3802
23. D.L. Doolan Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data Proc. Natl. Acad. Sci. U. S. A. 100 2003 9952 9957
24. A. Bahl PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data Nucleic Acids Res. 31 2003 212 215
25. L. Li Gene discovery in the apicomplexa as revealed by EST sequencing and assembly of a comparative gene database Genome Res. 13 2003 443 454
26. L. Li OrthoMCL: identification of ortholog groups for eukaryotic genomes Genome Res. 13 2003 2178 2189
27. J.C. Kissinger, and D.S. Roos Getting the most out of bioinformatics resources A.P. Waters C.J. Janse Malaria Parasites: Genomes and Molecular Biology 2004 Caister Academic Press
28. D.F. Clyde Immunization of man against sporozoite-induced falciparum malaria Am. J. Med. Sci. 266 1973 169 177
29. R.S. Nussenzweig Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei Nature 216 1967 160 162
30. S.L. Hoffman Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites J. Infect. Dis. 185 2002 1155 1164
31. D. Butler Mosquito production mooted as fast track to malaria vaccine Nature 425 2003 437
32. A.S. Bell, and L.C. Ranford-Cartwright A real-time PCR assay for quantifying Plasmodium falciparum infections in the mosquito vector Int. J. Parasitol. 34 2004 795 802
33. D.L. Doolan, and S.L. Hoffman The complexity of protective immunity against liver-stage malaria J. Immunol. 165 2000 1453 1462
34. K.A. Bojang Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial Lancet 358 2001 1927 1934
35. D. Schellenberg Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial Lancet 357 2001 1471 1477
36. S.J. Dunachie, and A.V. Hill Prime-boost strategies for malaria vaccine development J. Exp. Biol. 206 2003 3771 3779
37. K.E. Kester Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria J. Infect. Dis. 183 2001 640 647
38. P. Sun Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4(+) and CD8(+) T cells producing IFN-gamma J. Immunol. 171 2003 6961 6967
39. M. Pinder Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia Clin. Exp. Immunol. 135 2004 286 293
40. A. Morrot, and F. Zavala Effector and memory CD8+ T cells as seen in immunity to malaria Immunol. Rev. 201 2004 291 303
41. E.J. Wherry Lineage relationship and protective immunity of memory CD8 T cell subsets Nat. Immunol. 4 2003 225 234
42. J.C. Hafalla Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria J. Immunol. 171 2003 964 970
43. P. Wong, and E.G. Pamer Feedback regulation of pathogen-specific T cell priming Immunity 18 2003 499 511
44. V.S. Moorthy Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults J. Infect. Dis. 188 2003 1239 1244
45. I.N. Crispe Hepatic T cells and liver tolerance Nat. Rev. Immunol. 3 2003 51 62
46. F. Zavala A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells Virology 280 2001 155 159